MILLENNIUM MANAGEMENT LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$3,638
-87.8%
866,152
-82.5%
0.00%
-88.2%
Q4 2022$29,826
-99.9%
4,962,769
+4.4%
0.02%
+6.2%
Q3 2022$27,669,000
+46.3%
4,754,128
+50.1%
0.02%
+33.3%
Q2 2022$18,913,000
+85.9%
3,168,087
+45.4%
0.01%
+140.0%
Q1 2022$10,174,000
+1891.0%
2,178,563
+956.8%
0.01%
Q4 2021$511,000
-51.2%
206,147
-41.9%
0.00%
-100.0%
Q3 2021$1,048,000
+47.4%
355,099
+24.9%
0.00%
Q2 2021$711,000
-43.9%
284,216
-34.8%
0.00%
-100.0%
Q1 2021$1,268,000
+3.1%
435,600
+14.0%
0.00%0.0%
Q4 2020$1,230,000
+1632.4%
382,055
+528.4%
0.00%
Q2 2020$71,000
+108.8%
60,798
+65.3%
0.00%
Q1 2020$34,000
+100.0%
36,780
+238.2%
0.00%
Q4 2019$17,000
-90.6%
10,876
-95.0%
0.00%
Q3 2019$181,000
-69.5%
218,484
-68.3%
0.00%
-100.0%
Q2 2019$593,000
-82.4%
689,551
+1.9%
0.00%
-75.0%
Q2 2018$3,370,000
+9.8%
676,755
-14.0%
0.00%0.0%
Q1 2018$3,068,000
+1327.0%
786,583
+1067.9%
0.00%
Q3 2017$215,000
-67.8%
67,352
-57.7%
0.00%
-100.0%
Q1 2017$668,000159,1200.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,049,298$20,166,00012.25%
BVF INC/IL 6,929,690$34,510,0003.37%
GREAT POINT PARTNERS LLC 1,537,020$7,654,0001.06%
NEA Management Company, LLC 3,750,000$18,675,0000.88%
SPHERA FUNDS MANAGEMENT LTD. 874,407$4,355,0000.60%
Orbimed Advisors 5,000,000$24,900,0000.30%
ALGERT GLOBAL LLC 218,023$1,086,0000.22%
Opaleye Management Inc. 161,400$803,0000.21%
Alambic Investment Management, L.P. 123,976$617,0000.17%
DRIEHAUS CAPITAL MANAGEMENT LLC 604,596$3,011,0000.10%
View complete list of CTI BIOPHARMA CORP shareholders